CD200R1 and breast carcinoma: In breast cancer (BC), RNAseq revealed increased expression of transcripts encoding immune regulatory receptors (CD200R1), pro-apoptotic molecules (TNFSF10), and pro-angiogenic factors (HGF and ANGPT1) in BC patients compared to healthy donors (17).